BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19049839)

  • 1. Importance of accurate diagnosis in the assessment of impact of immunisation campaigns: case study of a measles immunisation programme in Madagascar.
    Garry SF
    Public Health; 2009 Jan; 123(1):72-3. PubMed ID: 19049839
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress toward measles eradication in the region of the Americas.
    De Quadros CA; Izurieta H; Carrasco P; Brana M; Tambini G
    J Infect Dis; 2003 May; 187 Suppl 1():S102-10. PubMed ID: 12721900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interruption of indigenous measles transmission in Bolivia since October 2000.
    Quiroga R; Barrezueta O; Venczel L; Halkyer P; Gil F; Machicao E; Landaverde M; Quiñonez A; Izurieta H
    J Infect Dis; 2003 May; 187 Suppl 1():S121-6. PubMed ID: 12721902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues.
    Pless RP; Bentsi-Enchill AD; Duclos P
    J Infect Dis; 2003 May; 187 Suppl 1():S291-8. PubMed ID: 12721928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated measles control--Cambodia, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of measles transmission in Brazil, 2000-2001.
    Prevots DR; Parise MS; Segatto TC; Siqueira MM; dos Santos ED; Ganter B; Perreira MC; Domingues CA; Lanzieri T; Da Silva JB
    J Infect Dis; 2003 May; 187 Suppl 1():S111-20. PubMed ID: 12721901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles eradication in the Americas: experience in Haiti.
    Venczel L; Dobbins J; André J; Laender F; Izurieta H; Delorme P; Voltaire HC
    J Infect Dis; 2003 May; 187 Suppl 1():S127-32. PubMed ID: 12721903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010.
    Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S164-71. PubMed ID: 12721909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles epidemics 1949-91: the impact of mass immunisation in New Zealand.
    Cullen RM; Walker WJ
    N Z Med J; 1996 Oct; 109(1032):400-2. PubMed ID: 8937390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of measles elimination strategies in the United States.
    Hinman AR; Orenstein WA; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S17-22. PubMed ID: 15106084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
    East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary and conclusions: measles elimination meeting, 16-17 March 2000.
    Katz SL; Hinman AR
    J Infect Dis; 2004 May; 189 Suppl 1():S43-7. PubMed ID: 15106088
    [No Abstract]   [Full Text] [Related]  

  • 14. The elimination of indigenous measles transmission in England and Wales.
    Ramsay ME; Jin L; White J; Litton P; Cohen B; Brown D
    J Infect Dis; 2003 May; 187 Suppl 1():S198-207. PubMed ID: 12721914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles surveillance.
    CDR (Lond Engl Wkly); 1991 Dec; 1(50):221. PubMed ID: 1669898
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles eradication in the Americas: progress to date.
    de Quadros CA; Izurieta H; Venczel L; Carrasco P
    J Infect Dis; 2004 May; 189 Suppl 1():S227-35. PubMed ID: 15106116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in measles control--Kenya 2002-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):969-72. PubMed ID: 17882128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles vaccine efficacy evaluated by case reference technique.
    Puri A; Gupta VK; Chakravarti A; Mehra M
    Indian Pediatr; 2002 Jun; 39(6):556-60. PubMed ID: 12084949
    [No Abstract]   [Full Text] [Related]  

  • 20. The global burden of measles in the year 2000--a model that uses country-specific indicators.
    Stein CE; Birmingham M; Kurian M; Duclos P; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S8-14. PubMed ID: 12721886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.